chrisvoncsefalvay/vaers-outcomes huggingface dataset:
high blood pressure; also have a little headache too; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09May2023 as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 10May2023, outcome "unknown", described as "also have a little headache too"; HYPERTENSION (non-serious) with onset 10May2023, outcome "unknown", described as "high blood pressure". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hypertension, headache.  Additional information: The patient took some TYLENOL but that didn't really touch it.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
significant swelling under her arm, on the arm she got the shot; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Dec2021 (Lot number: 3313084) at the age of 17 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Manufacturer unknown, Dose:1), for Covid-19 immunization; Covid-19 vaccine (Manufacturer unknown, Dose:2), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 10Dec2021, outcome "unknown", described as "booster"; PERIPHERAL SWELLING (non-serious) with onset 12Dec2021, outcome "recovering", described as "significant swelling under her arm, on the arm she got the shot". Therapeutic measures were taken as a result of peripheral swelling.  Additional information: Patient received the treatment for the event "significant swelling under her arm, on the arm" as Ibuprofen.  No follow-up attempts are possible. No further information is expected.
Within 45 minutes, my neck and face became hot and red. No issues with breathing, 6 hours later, I received a rash over the arm in which I had the injection. Since the shot Monday, I have continued to have redness on neck and face and along with felling hot. I have been taking Benadryl since Monday and finally went to UC on Thursday 01/07/2021. At the appointment, I received a Decadron injection, which helped, but today I am back to red face/neck and warmth.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On an unknown dates, the patients were administered an unspecified number of improperly stored doses of ROTATEQ lot # L008574, expiration date 22-NOV-2017 (dose and route of administration were not reported). No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
I was required to stay 15 minutes and was very dizzy. I was having severs pains in kidney and lungs. 7 days after vaccine I took my medication (Fasenrapen) I had been on for a year my throat swelled up.
Swollen hard arm,   4 days after -Light headed,  Dizzy,  Vomitting,   Rash appeared about 5-6 days after shot,  still have
Patient received her second dose of Moderna on her left arm on June 5th 2021.  The local injection site irritation was normal to her. Three to four weeks later, she experienced a sharp pain during a lifting. The pain was at the middle part of her upper left arm, not her shoulder, not the injection site.  Her doctor told her to watch the symptom at that time. Last week (more than 2 months after her second Moderna shot), the sharp pain came back again during a lifting.  Patient mentioned this to our pharmacist since it was the same arm that she had her second Moderna Covid19 vaccine.  We told her to try cold compress around that painful site and follow up with physician. She dose have an appointment with her doctor at the end of August.
At exactly three weeks after receiving my vaccine, I woke up with a headache, body aches and a fever developed. My fever got up to 103 degrees. I took ibuprofen for that, and it brought my fever down to 101 degrees. I went to Urgent Care and got a COVID test, which came back negative. They told me to go home and rest. I took Tylenol also, trying to reduce my fever, but that really didn't help. After two days of feeling this way, I woke up and felt better.
Around 12:00 pm not feeling well. Clammy, nauseated, dizzy and felt like was going to pass out. To emergency department for evaluation. Treated with IV fluids and antiemetics and discharged home.
2x2 cm of induration of left arm at site of prior HPV vaccine. Tender to touch slight overlying warmth.
Sore arm and swelling 4 hours after vaccination. Fever, chills, nausea, body aches, head ache 12 hours after vaccination which lasted through the entire night into the next day
This spontaneous report was received from a prescriber nurse referring to multiple unspecified patients (age and gender unknown). No information regarding the patients' concurrent conditions, medical history, drug reactions or allergies, and concomitant therapies was provided. The reporter stated that, on unspecified dates, the patients were vaccinated with improperly stored doses of injectable VARIVAX (lot# M040139 with expiration date on 28-SEP-2018, and lot# M036292 with expiration date on 17-AUG-2018) (strength, dose, frequency, route of administration and anatomical location were not reported) for prophylaxis. The vaccine doses were exposed to a temperature excursion of "-1" Celsius degrees for 4 hours; digital data logger was involved and there were no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
Headache X 3 days Severe Abdominal pain X 3 days Intermittent Nausea X 3 days Severe muscle and joint pain X 3 days Lightheadedness X 3 days Fatigue X 3 days Chills X 3 days Injection site red, hot, swollen and painful with itching and stinging sensation STILL CONTINUING TODAY WHICH IS DAY 4.
TINGLING, FEVER LOSS OF BLADDER CONTROL HEADACHE LOST APPETITE.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site reaction in a 61-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was unknown. It was unknown if the reporter considered the injection site reaction to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported, but the patient could be 60 or 61 years old. The batch number and expiry date for SHINGRIX was not reported. The patient experienced a local non-allergic reaction (an injection site thing). The reporter consented to follow up.
Puritic rash and itching noted on L arm around injection site. Later on 10/18 R arm started itching and rash was noticed. When I awoke on 10/19 my body was covered in a puritic rash and had severe itching. Nothing changed in my routines- no food changes, no body care changes, no laundry detergent changes. Itching and rash worsened, left work to go to MD at 12noon on 10/19. MD stated likely an allergic reaction to the flu shot. Methylprednisolone dose pack and Benedryl started on 10/19. Rash and itching still present on 10/20, but significantly reduced.
Anxiety attack for the first time in my life at a local bar. Had to sit down because I had no idea what was happening. Dizzy, light headed, felt like I could not breathe.
Flu like symptoms with localized pain and swelling occurring within 24 hours of injection. Developed urticaria, not around injection site, but to left upper arm and chest >2 days after receiving vaccine.
Left thigh - swelling and redness approx 2" in diameter around injection site. Child has no pain when are touched. 5:05 PM Benadryl 3/4 tsp po. 5:10 PM redness decreased, sq.
Patient developed petechiae, swelling with induration about 10 cm after Tdap in his right arm. On left arm developed a 12cm area of swelling and induration after recieving HPV and MCV4. Evaluated by attending MD here at the clinic. No other symptoms.
J96.00 ACUTE RESPIRATORY FAILURE 12/28/2022 CHEST PAIN
This was a COVID booster. I had a terrible headache, terrible body aches, body chills and a fever, and insomnia for the entire day following the shot. I am still experiencing exhaustion and arm pain at the injection site.
pt t97.3 seen to recheck lotitis (rx'd w/10 days pedizole) 9SEP93; give ped vax HIB 9SEP93 10AM by 11AM had sore lt leg & limp; napped 1 1/2 hrs; had 6 emeses between 1230PM & 6PM; sl induration of lt thigh;
Pneumococcal Meningitis. 2/21/06 Received medical records which revealed patient experienced hx of VSD, cardiac murmur, asthma, environmental allergies.  Nausea w/vomiting, abdominal pain, headache, neck pain & stiffness, fatigue, poor appetite & fever prior to admission.  Dx with bacterial meningitis.
Red raised rash p/1st & 2nd series of DPT & OPV & Hib given; 1st rash was slight, rash p/2nd series covered torso & part of face; both rashes broke out 2 days p/immuns given; t99-100 during the rash; rash lasted 4-5 wks p/2nd immuns given;
2nd day p/inject noted swelling & itching @ inject site lt deltoid; Also enlarged supra clavicular node on lt; lt arm, neck & upper chest discomfort;
still kind of hot felt hot; red spot (injection site); little swollen; very very itching/felt like scratching around the area; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (still kind of hot felt hot), VACCINATION SITE ERYTHEMA (red spot (injection site)), VACCINATION SITE SWELLING (little swollen) and VACCINATION SITE PRURITUS (very very itching/felt like scratching around the area) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hypertension.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FEELING HOT (still kind of hot felt hot), VACCINATION SITE ERYTHEMA (red spot (injection site)), VACCINATION SITE SWELLING (little swollen) and VACCINATION SITE PRURITUS (very very itching/felt like scratching around the area). At the time of the report, FEELING HOT (still kind of hot felt hot), VACCINATION SITE ERYTHEMA (red spot (injection site)) and VACCINATION SITE SWELLING (little swollen) had not resolved and VACCINATION SITE PRURITUS (very very itching/felt like scratching around the area) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other medications include high blood pressure medicine. Treatment information not provided.
Couldn't get up of bed; sore arm; muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Couldn't get up of bed), PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety, Blood pressure, Multiple allergies (Patient is allergic to everything .) and Acne. Concomitant products included AZELAIC ACID for Acne, DIAZEPAM for Anxiety.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (Couldn't get up of bed), PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle ache). At the time of the report, BEDRIDDEN (Couldn't get up of bed), PAIN IN EXTREMITY (sore arm) and MYALGIA (muscle ache) outcome was unknown.            Treatment medication information was not provided.  Concomitant medicine included Tersac  and patient is on blood pressure pills.  Cardiac Lab values (ECG, cardiac test, cardiac enzymes) The patient had an appointment in November to get some cardiac test.   This case was linked to MOD-2021-370454, MOD-2021-371161, MOD-2021-373064 (Patient Link).
Pt was nervous before getting shot.  After receiving shot he was in a monitor area.  He raised hand and stated he felt weak.  He was pale and diaphoretic.  Helped him to ground and allowed to rest. Felt better. Pt evaluated by paramedics.  VS @ 1107 HR 68, OxSat 99%, BP 96/47.  @1115 Sit in chair.  BP 104/56, HR 70, OxSat 100%.  @ 11:45 Pt ambulated w/o difficulty.  Taking bus home.  Told to call nurse when he arrives home.
Vaccine that administered beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 prophylaxis.     Patient allergies to medications, food and other products were unknown.  Concurrent medical conditions included Immunocompromised.    On 11-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 11-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that vaccine was administered beyond use date to the patients. There was no adverse reaction noted or reported regarding these administrations.  It was unknown that if the vaccine had undergone any temperature excursion issue.  Vaccine NDC code.  No treatment medication was provided.
On Thursday, June 28 , 2007 I received a call from patient, who had received Zostavax on June 22, 2007 at the Pickens County Health Department. She stated that on the day before (June 27th) she had noticed 6-7 "small bumps" mid-thorax beneath her bra lines as well as one on her left hip which appeared to be fluid-filled. She called to ask whether this might be a reaction to her immunization. She encouraged to have her physician examine the area. She had had no known recent exposure to chicken pox or shingles. Her husband had had shingles one year ago. I spoke to patient the following day, June 29th. She had seen a physician at an urgent care center who confirmed that the outbreak was definitely a shingles-like outbreak. The physician treated her with an anti-viral and a steroid dose-pack, and cautioned patient that the steroids would likely null any immunity she might have gotten from the vaccine. I spoke with patient that next week and was told that the outbreak had gone away. She had discontinued the steroids after the 2nd day due to the sleeplessness it caused. She stated that she currently has no symptoms.
6AUG96 pt recv vax & 9AUG96 site swollen & red; 18AUG96 red rash over entire body;19AUG96 seen by MD-felt to be rxn ATB;
2 days after vaccine the injection site arm has become red, itchy, swollen, hot and hivey.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. On an unknown date in 2016, the patient was vaccinated with the first dose of GARDASIL 9 (lot # and expiration date were unknown). In April 2017, the patient was vaccinated with the second dose of GARDASIL 9 (lot # and expiration date were unknown). In June 2017, the patient was vaccinated with the third dose of GARDASIL 9, lot # N003703 with expiration date on 29-OCT-2019. The patient had an altered dosing schedule of GARDASIL 9. No adverse effects were reported. Product quality complaint was not involved. Additional information has been requested.
Shortness of Breath      Per pt, "I've tested positive for covid 9 days ago. I feel a lot better but my wife made me come in."        HPI:   This is a 43y.o. male with significant past medical history of HTN, T2DM, and morbid obesity that presented to the hospital with chief complaint of COVID-19 infection. He reports he became symptomatic on 11/17 and tested positive on 11/22. He has since had worsening headache, loss of smell, and diarrhea. He developed shortness of breath yesterday prompting him to seek ED evaluation. He denies any fever, chills, chest pain, palpitations, cough, abdominal pain, nausea, vomiting, constipation, or urinary complaints.    In the ED, patient normotensive, afebrile, stable SPO2 on room air. Cr 1.78, troponin 0.05, d-dimer 755. EKG with sinus tachycardia. CXR with multifocal pneumonia. He has been admitted for further evaluation and management with ID consultation.    Patient seen and examined only by the attending physician; NP only responsible for chart review in an effort to limit exposure given the patient's COVID positive status.
pt recv vax & 10 to 12 wk later pt exp a negative titer for rubella antibody;
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies provided. On 08-JUL-2016, the patient was vaccinated with an expired dose of ROTATEQ (lot# K010222, expiration date 31-MAY-2-16, dose was not reported; orally). No adverse events were reported. Additional information has been requested.
This case was reported by a healthcare professional and described the occurrence of unspecified adverse reaction in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine (Flu vaccine, manufacturer unspecified) for prophylaxis. On an unspecified date, approximately four years ago, the subject received unspecified dose of Flu vaccine (unknown) and experienced an unspecified adverse reaction in 2001. The healthcare professional reported that the subject reacted to the neomycin component of the flu vaccine. At the time of reporting the outcome of the event was unspecified.
DIZZY; CHILLS; LEFT ARM PAIN AT INJECTION SITE; FEVER; HEADACHE; VOMITING; LEFT-SIDE STOMACH PAIN; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included latex allergy, alcohol user (twice a month), and non-smoker, and other pre-existing medical conditions included the patient had no illicit drug usage and drug abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced vomiting. On 13-APR-2021, the subject experienced left-side stomach pain. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced left arm pain at injection site. On 13-APR-2021, the subject experienced fever. On 13-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102.5 F, Heart rate (NR: not provided) 120 BPM, and Pulse oximetry (NR: not provided) 91 %. On 16-APR-2021, the subject experienced dizzy. Laboratory data included: Body temperature (NR: not provided) 99 F. Treatment medications (dates unspecified) included: ibuprofen, acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, left-side stomach pain, and chills on 16-APR-2021, was recovering from dizzy, and had not recovered from headache, fever, and left arm pain at injection site. This report was non-serious.
This spontaneous report was received from a Registered Nurse referring to a 14 year old male patient with drug reactions/allergies to penicillin. The patient's medical history was not reported. Concomitant medications included unspecified Inhaler for asthma. On 10-NOV-2017,  the patient was vaccinated with his first dose of GARDASIL 9 intramuscular route  (dose, frequency and anatomical location were unknown) with lot # N019923 and expiration date 28-APR-2019 recommended for prevention of Human papillomavirus (HPV). On an unknown date (reported as "few days later"), the patient developed doubled over intermittent abdominal pain, nausea, vomiting and diarrhea, these events continued since then and appeared  about once or twice a week. No laboratory diagnostics or studies were performed. The patient sought medical attention an visited the physician on 05-DEC-2017. The reporter did not mention the causality assessment between the aforementioned events and GARDASIL 9.
Fever, chills, abd pain, headaches, and personality changes which were problematic for a period of several months after the immunizations. She was seen multiple times by neurologists and GI as well as by her PCP for follow up of these symptoms.
Patient came to the pharmacy on 9/3 to pick up prescriptions after seeking treatment for ongoing arm pain following her flu shot on 8/21. Her provider thought that when she received the flu shot, the immunizer hit a tendon which is causing the patient ongoing pain.
Pt received both doses of the Moderna COVID-19 vaccine, on 3/13/2021 and 4/10/2021. She was admitted to an outside hospital for COVID-19 related symptoms of SOB and cough on 4/18/2021, then tested positive via PCR.  On 4/23/2021, she was transferred to this hospital for ICU level care.  She is still inpatient in our ICU
Patient reported large amount of bruising day after injection was given that has lasted over one week. Patient also experienced pain for one day.
DIFFICULTY IN STANDING; FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced difficulty in standing. On APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue and difficulty in standing was not reported. This report was non-serious.